Galectin-3 Is Associated with Cardiac Fibrosis and an Increased Risk of Sudden Death.
Mingma D SherpaSwati D SonkawadeVinesh JonnalaSaraswati PokharelMahyar KhazaeliYan YatsynovichMohamad A KalotBrian R WeilJohn M CantyUmesh C SharmaPublished in: Cells (2023)
Our study shows that increased gal3 is associated with a higher risk of myocardial fibrosis and the risk of SCD. This supports the importance of larger translational studies to target gal3 to prevent cardiac fibrosis and attenuate the risk of SCD.